Rapid genotyping of APOA5 -1131T>C polymorphism using high resolution melting analysis with unlabeled probes

Gene

Volumn 498, Issue 2, 2012, Pages 276-279

  Liu, Song mei ^a   Xu, Feng xia ^a   Shen, Fan ^a   Xie, Yan ^a  

^a WUHAN UNIVERSITY   (China)

Author keywords

Apolipoprotein A5; Genotyping; High resolution melting; Single nucleotide polymorphism

Indexed keywords

APOLIPOPROTEIN A5; TRIACYLGLYCEROL;

ACCURACY; ALLELE; ARTICLE; CONTROLLED STUDY; DNA DETERMINATION; DNA SEQUENCE; GENOTYPE; HIGH RESOLUTION MELTING ANALYSIS; HOMOZYGOTE; HUMAN; LIMIT OF DETECTION; MAJOR CLINICAL STUDY; NORMAL HUMAN; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

APOLIPOPROTEINS A; DNA PROBES; GENE FREQUENCY; GENETIC TECHNIQUES; HOMOZYGOTE; HUMANS; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84862784016     PISSN: 03781119     EISSN: 18790038     Source Type: Journal    
DOI: 10.1016/j.gene.2012.02.025     Document Type: Article

References (21)

1. Bi N., Yan S.K., Li G.P., Yin Z.N., Chen B.S. A single nucleotide polymorphism -1131T>C in the apolipoprotein A5 gene is associated with an increased risk of coronary artery disease and alters triglyceride metabolism in Chinese. Mol. Genet. Metab. 2004, 83:280-286.
2. Cabré A., et al. The APOA5-1131 T>C variant enhances the association between RBP4 and hypertriglyceridemia in diabetes. Nutr. Metab. Cardiovasc. Dis. 2010, 20:243-248.
3. Dobrowolski S.F., et al. Identifying sequence variants in the human mitochondrial genome using high-resolution melt (HRM) profiling. Hum. Mutat. 2009, 30:891-898.
4. Erali M., Wittwer C.T. High resolution melting analysis for gene scanning. Methods 2010, 50:250-261.
5. Francés F., Corella D., Sorlí J.V., Guillén M., González J.I., Portolés O. Validating a rapid method for detecting common polymorphisms in the APOA5 gene by melting curve analysis using LightTyper. Clin. Chem. 2005, 51:1279-1282.
6. Havasi V., et al. Apolipoprotein A5 gene promoter region T-1131C polymorphism associates with elevated circulating triglyceride levels and confers susceptibility for development of ischemic stroke. J. Mol. Neurosci. 2006, 29:177-183.
7. Hubacek J.A., et al. Impact of apolipoprotein A5 variants on statin treatment efficacy. Pharmacogenomics 2009, 10:945-950.
8. Hyun Y.J., et al. Association of apolipoprotein A5 concentration with serum insulin and triglyceride levels and coronary artery disease in Korean men. Atherosclerosis 2009, 205:568-573.
9. Jang Y., et al. The apolipoprotein A5 -1131T>C promoter polymorphism in Koreans: association with plasma APOA5 and serum triglyceride concentrations, LDL particle size and coronary artery disease. Clin. Chim. Acta 2009, 402:83-87.
10. Ken-Dror G., Goldbourt U., Dankner R. Different effects of apolipoprotein A5 SNPs and haplotypes on triglyceride concentration in three ethnic origins. J. Hum. Genet. 2010, 55:300-307.
11. Li Y., et al. The associations of IL-18 serum levels and promoter polymorphism with tacrolimus pharmacokinetics and hepatic allograft dysfunction in Chinese liver transplantation recipients. Gene 2012, 491:251-255.
12. Liew M., et al. Genotyping of single-nucleotide polymorphisms by high-resolution melting of small amplicons. Clin. Chem. 2004, 50:1156-1164.
13. Lyon E., Wittwer C.T. LightCycler technology in molecular diagnostics. J. Mol. Diagn. 2009, 11:93-101.
14. Maasz A., et al. Apolipoprotein A5 gene IVS3 +G476A allelic variant confers susceptibility for development of ischemic stroke. Circ. J. 2008, 72:1065-1070.
15. Maász A., Kisfali P., Szolnoki Z., Hadarits F., Melegh B. Apolipoprotein A5 gene C56G variant confers risk for the development of large-vessel associated ischemic stroke. J. Neurol. 2008, 255:649-654.
16. Ong K.L., et al. Association of a genetic variant in the apolipoprotein A5 gene with the metabolic syndrome in Chinese. Clin. Endocrinol. 2011, 74:206-213.
17. Pennacchio L.A., et al. An apolipoprotein influencing triglycerides in humans and mice revealed by comparative sequencing. Science 2001, 294:169-173.
18. Talmud P.J., et al. Relative contribution of variation within the APOC3/A4/A5 gene cluster in determining plasma triglycerides. Hum. Mol. Genet. 2002, 11:3039-3046.
19. Vossen R.H., van Duijn M., Daha M.R., den Dunnen J.T., Roos A. High-throughput genotyping of mannose-binding lectin variants using high-resolution DNA-melting analysis. Hum. Mutat. 2010, 31:E1286-E1293.
20. Willer C.J., et al. Newly identified loci that influence lipid concentrations and risk of coronary artery disease. Nat. Genet. 2008, 40:161-169.
21. Yan J.B., et al. Rapid and reliable detection of glucose-6- phosphate dehydrogenase (G6PD) gene mutations in Han Chinese using high-resolution melting analysis. J. Mol. Diagn. 2010, 12:305-311.